“Myopia’s growth has been dizzying, and now affects the vast majority of young adults in some countries, especially in East Asia,” said Arthur Back, Chief Technology Officer for CooperVision and a leading voice on myopia management. “Not only does it create blurred vision, but also increases the likelihood of conditions later in life such as glaucoma, cataract, retinal detachment and myopic maculopathy if not addressed.”
Why should you be interested in myopia control? Because slowing the progression of myopia may keep your child from developing high levels of short sightedness that require thick, corrective spectacles and have been associated with serious eye problems later in life, such as early cataracts or even a detached retina.
Although an outright cure for short sightesdness has not been discovered, there are a number of treatments that may be able to slow the progression of myopia.
These treatments can induce changes in the structure and focusing of the eye to reduce stress and fatigue associated with the development and progression of short sightedness.
Previously there were four types of treatment showing promise for controlling myopia:
- Atropine eye drops
- Multifocal contact lenses
- Orthokeratology ("ortho-k")
- Multifocal eyeglasses
But now available is a fifth type of treatment - an Innovative optical design contact lens:
MiSight® 1 day daily disposable contact lens with ActivControl® myopia management technology.
MiSight® 1 day contact lenses control both axial length increase and myopia progression while fully correcting refractive error3,4